Table 2. Cox proportional hazard regression analysis for overall survival.
Univariatea |
Multivariateb |
|||
---|---|---|---|---|
Factor | P-valuec | HR | 95%CI | P-valuec |
Gender | ||||
Male vs female | 0.6793 | — | ||
Age (years) | ||||
⩾60 vs <60 | 0.0294 | — | ||
Location | ||||
Upper vs middle/lower | 0.0296 | 2.776 | 1.125–6.27 | 0.0282 |
Histological grade | ||||
Undifferentiated vs differentiated | 0.8722 | — | ||
Macroscopic appearance | ||||
Type 3/4/5 vs type 0/1/2 | <0.0001 | |||
Tumour size (mm) | ||||
⩾60 vs <60 | <0.0001 | 2.842 | 1.336–6.44 | 0.0063 |
Venous invasion | ||||
Positive vs negative | <0.0001 | — | ||
Lymphatic invasion | ||||
Positive vs negative | <0.0001 | — | ||
pT-stage | ||||
pT 2/3/4 vs pT 1 | <0.0001 | 14.48 | 1.611–310.70 | 0.0164 |
pN-stage | ||||
pN 1/2/3 vs pN 0 | <0.0001 | 4.14 | 1.242–23.31 | 0.0174 |
PBK/TOPK expressiond | ||||
High vs low | 0.0009 | 6.403 | 2.712–14.49 | <0.0001 |
p53 (DO7) | ||||
Positive vs negative | 0.5273 |
Abbreviations: CI=confidence interval; HR=hazard ratio.
Statistically significant values are in boldface type.
Kaplan and Meier method, and the statistical significance was determined by log-rank test.
Multivariate survival analysis was performed using Cox's proportional hazard model.
P-values were from two-sided tests and were statistically significant at <0.05.
PBK/TOPK expression was evaluated by immunohistochemical analysis as described in Materials and Methods.